Therapeutic microRNA strategies in human cancer.

Détails

ID Serval
serval:BIB_3E3C6E8EF57F
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Therapeutic microRNA strategies in human cancer.
Périodique
AAPS Journal
Auteur⸱e⸱s
Li C., Feng Y., Coukos G., Zhang L.
ISSN
1550-7416 (Electronic)
ISSN-L
1550-7416
Statut éditorial
Publié
Date de publication
2009
Volume
11
Numéro
4
Pages
747-757
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; ReviewPublication Status: ppublish
Résumé
MicroRNAs (miRNAs) are approximately 22 nucleotide long, noncoding, endogenous RNA molecules which exert their functions by base pairing with messenger RNAs (mRNAs), thereby regulate protein-coding gene expression. In eukaryotic cells, miRNAs play important roles in regulating biological processes such as proliferation, differentiation, apoptosis, and stem cell self-renewal. The human genome may contain as many as 1,000 miRNAs, and more than 700 of them have been identified. miRNAs are predicted to target up to one third of mRNAs. Each miRNA can target hundreds of transcripts directly or indirectly, while more than one miRNA can converge on a single transcript target. Therefore, the potential regulatory circuitry afforded by miRNA is enormous. Recently, mounting evidence implicates miRNAs as a new class of modulator for human tumor initiation and progression. Therefore, it has been proposed that manipulating miRNA activity and miRNA biogenesis may be a novel avenue for developing efficient therapies against cancer.
Mots-clé
Gene Expression Regulation, Neoplastic/genetics, Gene Silencing, Gene Targeting, Genes, Tumor Suppressor/physiology, Genetic Therapy/methods, Humans, MicroRNAs/administration & dosage, MicroRNAs/biosynthesis, Neoplasms/genetics, Neoplasms/therapy, Neoplastic Stem Cells, Oncogenes/genetics, RNA, Small Interfering/administration & dosage, RNA, Small Interfering/therapeutic use
Pubmed
Création de la notice
14/10/2014 12:43
Dernière modification de la notice
20/08/2019 14:34
Données d'usage